L27.8
Dermatitis due to other substances taken internally
Clinical Classification Guidelines
Medical Intelligence & Overview
Dermatitis due to other substances taken internally, classified under ICD-10 code L27.8, is a skin condition characterized by inflammation resulting from the body's reaction to specific substances consumed internally. This type of dermatitis is distinct because it is caused by substances ingested or otherwise introduced into the body, leading to skin irritation and allergic responses. Recognizing the signs and understanding the underlying causes can aid in effective management and treatment of this condition.
Causes & Symptoms
Clinical Causes: Certain medications taken orally that trigger allergic skin reactions Dietary components or food additives causing hypersensitivity reactions Supplements or herbal products containing allergens or irritants Ingested chemicals or toxins resulting in allergic dermatitis Other substances introduced internally that provoke immune responses
Key Symptoms: Redness and swelling of the skin Itching and discomfort in affected areas Development of blisters or hives on the skin surface Rash that may spread or appear in patches Possible scaling or dryness of the skin Localized or widespread skin irritation depending on severity
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough review of the patient’s medical history, including recent medication use and dietary intake. Physical examination focuses on identifying the location and characteristics of skin lesions. In some cases, skin patch testing or blood tests may be conducted to identify specific allergens responsible for the dermatitis. The goal is to differentiate this condition from other types of dermatitis and skin allergies to initiate appropriate treatment and management strategies.
Treatment Protocols: Treatment primarily targets the underlying cause and aims to relieve symptoms. Approaches may include: - Avoiding the identified offending substances to prevent further reactions - Use of topical corticosteroids to reduce inflammation and itching - Oral antihistamines to control allergic responses - Maintaining skin hydration with emollients to aid recovery - Monitoring and managing any secondary infections if they arise In some cases, healthcare providers might recommend allergy testing or consultations with specialists to better identify triggers and prevent future episodes.
Clinical Advice & FAQs
Billing Guidance
Is L27.8 a billable ICD-10 code?
Yes, L27.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L27.8?
Clinical documentation must specify the nature of Dermatitis due to other substances taken internally and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
